With respect to the RA and AS subsets, TNF inhibition increased anti-CS IgM and anti-TOPO-F4 IgG in RA and anti-CS IgM and, transiently, IgG in AS. The gene discussed is CD40LG; the disease is rheumatoid arthritis.